A

Alkeus Pharmaceuticals

Alkeus Pharmaceuticals is a biotechnology startup focused on developing a treatment for Stargardt disease, a genetic condition that leads to progressive vision loss. The company is notable for its innovative drug, gildeuretinol, which has shown promise in clinical trials and is now being acquired by Tarsus Pharmaceuticals for up to $800 million.

Total raised
$800M
tracked to date
Latest round
$800M
Aug 6, 2026
Known investors
2
led by Bain Capital Life Sciences

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 USA Funding Report

Read the Q3 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 USA Funding Report</a>

Funding history

  1. 1
    $800MAug 6, 2026

    Led by Bain Capital Life Sciences

    Announcement ↗

Founder

L
Leonide Saad
Founder

Investors in Alkeus Pharmaceuticals

Backers from this company's tracked funding rounds.

  • BBain Capital Life SciencesLead investorVC firm
  • TTCGXVC firm

Alkeus Pharmaceuticals in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile